Check-Cap Ltd..
CHEK.US | Research and experimental development on natural sciences and engineering
Check-Cap Ltd. is an Israel-based medical diagnostics company focused on the development of C-Scan, an ingestible capsule-based screening system for colorectal cancer (CRC) screening. The company's primary activity revolves around the research, development, and eventual commercialization of this med...Show More
Better Health for All
0
No evidence available to assess Check-Cap Ltd. on Better Health for All.
Fair Money & Economic Opportunity
0
Check-Cap Ltd. is a medical diagnostics company focused on developing a capsule-based screening system for colorectal cancer.
1
explicitly states that the company's business is medical diagnostics, not financial services or social impact initiatives. As the company does not operate in the financial sector,
2
all KPIs related to 'Fair Money & Economic Opportunity,' which assess financial institutions on aspects like lending, fees, financial inclusion, and customer wealth building, are not applicable to Check-Cap Ltd. Therefore, all relevant KPIs are assigned a score of 0, indicating they are not applicable to the company's core business.
Fair Pay & Worker Respect
0
Check-Cap Ltd. has a workforce of 8 employees following a reduction.
1
, which places it in the 'N/A' category for living wage coverage as per the rubric's threshold for organizations with fewer than 10 employees. Additionally, there is no public record of labor-law or human-rights violations mentioned in the provided articles for the past three years.
2
No specific, concrete data points were found for CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, voluntary turnover rate, insecure contract share, or health insurance coverage.
3
Fair Trade & Ethical Sourcing
0
No specific, quantitative evidence for Check-Cap Ltd. (CHEK.US) regarding fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, spend on high-risk materials, or supplier diversity spend was found in the provided articles. The articles discuss general industry practices, regulatory frameworks, or the policies of other companies, but do not offer any direct data points for CHEK.US.
Honest & Fair Business
-40
Check-Cap has a Code of Business Conduct and Ethics from 2017 which includes a whistleblower policy that encourages employees to report violations to a supervisor or the Audit Committee Chairman, and prohibits retaliation.
1
The company also has an anti-bribery policy that strictly prohibits bribery.
2
An independent research company, ISS, evaluated and confirmed the process and independence of the Check-Cap Board of Directors regarding a business combination, and recommended shareholder votes in favor of the transaction.
3
However, the company has faced significant governance issues, including an auditor resignation in February 2024 due to "certain control concerns," high turnover with seven directors resigning since January 2024 and at least three CEOs and four CFOs in less than 1.5 years, and a Nasdaq non-compliance letter in May 2025 for failing to file its annual financial report (Form 20-F for year ended December 31, 2024).
4
Kind to Animals
0
No evidence available to assess Check-Cap Ltd. on Kind to Animals.
No War, No Weapons
0
No evidence available to assess Check-Cap Ltd. on No War, No Weapons.
Planet-Friendly Business
0
The provided articles offer limited information regarding Check-Cap Ltd.'s direct environmental performance. While the company's C-Scan screening system is noted to have environmental benefits, such as 87% lower CO2 emissions and 65% less medical waste compared to traditional screening methods, and 92% of its device materials are recyclable, these are product-level comparisons or statements about product attributes.
1
There is no specific data on the company's total Scope 1, 2, and 3 greenhouse gas emissions, renewable energy usage, water consumption, waste diversion rates for its operations, or any climate-related targets or policies for the company itself.
Respect for Cultures & Communities
0
No evidence available to assess Check-Cap Ltd. on Respect for Cultures & Communities.
Safe & Smart Tech
0
The provided articles, primarily SEC filings, do not contain specific, concrete evidence related to Check-Cap Ltd.'s performance on any of the 'Safe & Smart Tech' KPIs. Information regarding data breaches, AI ethics governance, cybersecurity investment, privacy certifications, security training, encryption, AI audit practices, algorithmic transparency, unauthorized data use, user data control, authentication security, vulnerability management, bug bounty programs, privacy by design, security testing, data minimization, regulatory compliance specific to privacy, algorithmic harm remediation, or digital rights advocacy is explicitly stated as 'No relevant evidence' or 'No information found' within the provided texts.
1
While the company holds certifications like ISO 13485:2016 and CE Mark, these pertain to medical device quality management and market access, not privacy or security.
2
Therefore, no KPIs can be scored.
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles regarding Check-Cap Ltd.'s performance on any of the Zero Waste & Sustainable Products KPIs. Article 5 explicitly states that sustainability data is currently unavailable for CHEK.US.
1
Article 3, focusing on the company's manufacturing expansion, also confirms that no data related to waste diversion, product recyclability, packaging sustainability, or other relevant metrics is provided.
2